The rationale for targeting TGF-β in chronic liver diseases

European Journal of Clinical Investigation
Gianluigi GiannelliAránzazu Sánchez

Abstract

Transforming growth factor (TGF)-β is a pluripotent cytokine that displays several tissue-specific biological activities. In the liver, TGF-β is considered a fundamental molecule, controlling organ size and growth by limiting hepatocyte proliferation. It is involved in fibrogenesis and, therefore, in worsening liver damage, as well as in triggering the development of hepatocellular carcinoma (HCC). TGF-β is known to act as an oncosuppressor and also as a tumour promoter in HCC, but its role is still unclear. In this review, we discuss the potential role of TGF-β in regulating the tumoural progression of HCC, and therefore the rationale for targeting this molecule in patients with HCC. A considerable amount of experimental preclinical evidence suggests that TGF-β is a promising druggable target in patients with HCC. To support this hypothesis, a phase II clinical trial is currently ongoing using a TGF-β pathway inhibitor, and results will soon be available. The identification of new TGF-β related biomarkers will help to select those patients most likely to benefit from therapy aimed at inhibiting the TGF-β pathway. New formulations that may provide a more controlled and sustained delivery of the drug will improve the therapeutic...Continue Reading

References

Feb 2, 1999·Journal of Hepatology·C HellerbrandD A Brenner
May 5, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S DooleyA M Gressner
Jun 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·B SchnablD A Brenner
Aug 30, 2001·Proceedings of the National Academy of Sciences of the United States of America·T BrabletzT Kirchner
Apr 2, 2002·World Journal of Gastroenterology : WJG·Wei-Xing ChenFeng Chen
Dec 6, 2003·The EMBO Journal·Daizo KoinumaKohei Miyazono
Feb 12, 2005·Carcinogenesis·Alexandra N M FischerWolfgang Mikulits
Dec 14, 2005·Alcoholism, Clinical and Experimental Research·Katja BreitkopfSteven Dooley
Apr 11, 2006·Clinical Science·Piero PortincasaFrans Stellaard
Sep 13, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John NemunaitisHabib Fakhrai
Sep 20, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Hashem B El-Serag
Oct 20, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Carlo BergaminiGianluigi Giannelli
Jan 25, 2008·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Ana Castellano-HigueraRicardo Pelazas-González
Feb 6, 2008·Cancer Letters·Gianluigi GiannelliAngelo Paradiso
Mar 6, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Emilia FransveaGianluigi Giannelli
May 29, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Cédric CoulouarnSnorri S Thorgeirsson
Dec 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Emilia FransveaGianluigi Giannelli
Jan 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Keigo MachidaMichael M-C Lai
Mar 11, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patricio GodoySteven Dooley
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri, Robert A Weinberg
Jun 23, 2009·The Journal of Surgical Research·Vincenzo O PalmieriPiero Portincasa
Aug 28, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Antonio MazzoccaGianluigi Giannelli
Oct 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Antonio MazzoccaGianluigi Giannelli
Oct 27, 2009·Future Oncology·Franziska van ZijlWolfgang Mikulits
Oct 27, 2009·Development·Aristidis Moustakas, Carl-Henrik Heldin
Oct 31, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gianluigi Giannelli
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Mar 4, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rebecca G Wells
Jul 6, 2010·European Journal of Clinical Investigation·Ignazio GrattaglianoPiero Portincasa
Sep 17, 2010·Cancer Chemotherapy and Pharmacology·Emilia FransveaGianluigi Giannelli
Oct 20, 2010·The Journal of Pathology·Erik Meulmeester, Peter Ten Dijke
Nov 5, 2010·World Journal of Gastroenterology : WJG·Aránzazu Sánchez, Isabel Fabregat
Jan 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jairo OlivaresJohn Nemunaitis
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 19, 2011·Clinical Science·Angela SantamatoGianluigi Giannelli

❮ Previous
Next ❯

Citations

Dec 3, 2016·Regenerative Medicine·James Koudy Williams, Karl-Erik Andersson
May 26, 2017·Molecular Oncology·Dominic C VoonJean P Thiery
Oct 17, 2017·Journal of Molecular Cell Biology·Xiaohua YanYe-Guang Chen
Jan 21, 2017·Journal of Clinical Medicine·Takehiko Yokobori, Masahiko Nishiyama
May 12, 2018·Liver International : Official Journal of the International Association for the Study of the Liver·Annalisa AddanteAránzazu Sánchez
Jul 18, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christine HaiderWolfgang Mikulits
Feb 13, 2019·Alcoholism, Clinical and Experimental Research·Michael W Miller
Mar 12, 2019·Current Drug Metabolism·Hany A Abdel SamieMohammad A Kamal
Oct 17, 2019·Cells·Shuo TuXiaohua Yan
Jan 18, 2020·Expert Opinion on Investigational Drugs·Edward J Jarman, Luke Boulter
Mar 19, 2020·Cancers·Nada ChaoulFrancesco Dituri
Jan 6, 2018·Experimental & Molecular Medicine·Hadassa HirschfieldYujin Hoshida
May 29, 2018·Archives of Toxicology·Seddik HammadGianluigi Giannelli
Sep 27, 2018·Frontiers in Oncology·Isabel Fabregat, Daniel Caballero-Díaz
Aug 31, 2018·Acta Biochimica Et Biophysica Sinica·Shuchen Gu, Xin-Hua Feng
Apr 1, 2017·Hepatic Oncology·Isabel FabregatUNKNOWN IT-LIVER Consortium
May 27, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Xin-Xin GuoHui Zhang
Oct 6, 2018·Non-coding RNA·Patrick Ming-Kuen TangHui-Yao Lan
Feb 26, 2019·Frontiers in Medicine·Christian IhlingIsabelle Dussault
May 4, 2021·Gastroenterology·Nancy R GoughLopa Mishra
Jul 3, 2021·Cancers·Ester Gonzalez-SanchezIsabel Fabregat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Biochimica Et Biophysica Acta
Gianluigi GiannelliSalvatore Antonaci
Recenti progressi in medicina
Gianluigi Giannelli, Salvatore Antonaci
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Anja LachenmayerJosep M Llovet
© 2021 Meta ULC. All rights reserved